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Background: Tourette syndrome (TS) among young people is associated with psychosocial difficulties and parents
play an important role in the management of the condition. Clinical guidelines have been developed for the
treatment of TS and tics, but little is known about how young people and their parents perceive their treatment
options or their desired outcomes of treatment. The aim of this study is to explore perceptions of treatments for
tics among young people with TS and their parents.
Methods: In-depth interviews with 42 young people with TS and a mixed-methods, online survey of 295 parents
of young people with TS. Participant recruitment was conducted through Tourettes Action (TA): a non-profit UK
organisation for the support of people with TS. Interview transcripts were analysed using thematic analysis and
responses to survey open-ended questions were analysed using content analysis. Triangulation of qualitative and
quantitative data from the parents’ survey and qualitative data from the interviews with young people was used to
increase the validity and depth of the findings.
Results: A strong theme was the perception that health professionals have limited knowledge of TS and its
treatment. Medication was a common treatment for tics and both young people and parents described benefits of
medication. However, adverse effects were frequently described and these were a common reason for stopping
medication among young people. Aripiprazole was viewed most positively. Access to behavioural interventions for
tics was limited and 76% of parents wanted this treatment to be available for their child. Some young people had
reservations about the effectiveness or practicality of behavioural interventions. Reduction and abolition of tics were
desired outcomes of treatment, but both parents and young people also identified the importance of increasing
control over tics and reducing anxiety-related symptoms. For young people, managing the urge to tic was an
important outcome of treatment.
Conclusions: The results suggest a need for more training in the identification and management of TS and wider
availability of behavioural treatments. Clinical trials could explore the effectiveness of Aripiprazole used in
combination with psycho-educational interventions to reduce anxiety and promote a sense of control.
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Previously thought of as a rare condition, the prevalence
of Tourette syndrome (TS) in young people aged five to
18 years is now estimated to be between 0.4% and 3.8%
with an overall prevalence of 1% [1]. TS is defined by
multiple motor tics and the presence of at least one
vocal tic over a period of one year [2]. Some young
people with TS have been found to experience emotional
difficulties, to feel different or abnormal because of tics
[3] and to report problems relating with peers [4]. They
are also likely to face educational problems and [5] par-
ents of young people with TS report difficulties with
their child’s behaviour [6], with both of these difficulties
exacerbated by co-occurring conditions such as atten-
tion deficit hyperactivity disorder [7,5].
Some young people with TS require treatment to help
them manage their tics and the associated psychosocial
impairment [8]. Medication is the most common form
of treatment for tics [9,10], particularly risperidone, clo-
nidine and aripiprazole, among children and adolescents
[11]. Behavioural interventions for tics such as habit re-
versal are used more rarely [10] although current clinical
guidelines recommend that behavioural interventions for
tics are given as a first-line treatment [12-14] and medi-
cation when tics are severe and distressing [13]. Current
guidelines also emphasise the importance of providing
information about the condition to patients and family
[13,15,16]. Despite data on treatment utilisation patterns
and recent clinical recommendations, little is known
about how young people and key carers feel and think
about different treatments for tics.
The few studies that have explored young people’s and
parents’ perceptions of treatments for tics have mainly
focussed on the diagnostic process or on barriers to indi-
vidual treatments. A previous study of young people
with TS found a median delay of 2.8 years from age of
tic onset to age of diagnosis of TS [17]. Young people
with TS and their parents recently interviewed in a
Spanish study described difficulties receiving a diagnosis
of TS that were associated with a lack of knowledge
regarding tics among health professionals [18]. Further-
more, a survey study found that a common barrier for
treatment of tics was difficultiy finding knowledgeable
treatment providers [10]. There is some evidence sug-
gesting that parents of young people with TS have con-
cerns about adverse effects of medication for tics such as
antipsychotics [19].
The aim of this study was to explore how young
people with TS and parents of young people with TS
perceive different treatment strategies for tics, and to
explore similarities and differences between the views of
parents and young people. We integrated qualitative
data from in-depth interviews with young people with
TS, with quantitative and qualitative data from an onlinesurvey of parents of young people with TS. Combining
this evidence together increased the depth of the find-
ings and permitted a better understanding of how young
people with TS and their parents feel and think about
their treatment options. This research was part of a lar-
ger project examining the benefits and risks of different
types of treatment for tics in young people with TS
(Health Technology Assessment reference 10/142/01).
Methods
Participants and recruitment
The study had research ethics committee approval from
the Medical School Research Ethics Committee of the
University of Nottingham (reference number H07062012).
Survey of parents
Survey participants were parents or carers of young
people with TS or any tic disorder (referred to as “par-
ents” in the remainder of this paper). Exclusion criterion
was being a parent or carer of a young person aged over
17 years. Participants were recruited through study ad-
verts that were posted on the UK Tourettes Action (TA)
web site [20] and on its electronic newsletter. In addition,
invitation emails that included a link to the survey were
sent by TA to its members, and study leaflets were distrib-
uted at TA events such as conferences and group meet-
ings. Participants gave online consent to participate, the
survey was anonymous and it was available for six con-
secutive months (from December 2012 to May 2013).
Interviews with young people
Participants were children and young people with TS be-
tween 10 and 17 years of age (referred to as “young
people” in the remainder of this paper). Recruitment was
conducted through the online survey of parents, study
announcements posted in TA’s website and social media,
and through study leaflets distributed at TA’s informa-
tional events. Young people whose parents did not par-
ticipate in the survey were still eligible to take part in
the interviews.
Young people between 16 and 17 years of age, and
parents of young people aged 10 to 15 years, were con-
tacted to discuss the study in more detail, sent the infor-
mation sheet in print, a consent form and a freepost
envelope. Interviews were carried out at least one week
after the initial contact. On the day of the interview, par-
ents of young people aged 10 to 15 years were asked to
provide verbal informed consent, which was digitally re-
corded with their permission. In addition, after answer-
ing any questions about the study, their children were
asked to provide verbal consent to take part in the study
and this was digitally recorded. Young people between
16 and 17 years of age provided verbal informed consent
on the day of the interview.
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and aimed to include up to 50 young people depending
on the number of participants needed to achieve satur-
ation of themes (i.e., the point in the study when no new
themes are identified in the data). As past research has
identified treatment barriers for tics among young
people with TS [10], participants who were in the
process of receiving treatment or who have not received
treatment at the time of the interview were included in
the analysis. This allowed exploration of young peoples’
perceptions of access to care and perceived barriers to-
wards the use of different treatments for tics.
Data collection
Survey of parents
Target sample size was 300 participants based on Parker
et al. [21]. The survey was designed to collect informa-
tion about parents’ perceptions of treatment for their
children’s tics. Survey questions were developed based
on existing literature [8,13,10,17-19] and revised and
piloted by experts working with this population and
service users. The survey included forced choice tick
box responses (e.g., “yes” or “no”), rating scales, ranking
scales and text boxes for open comments. Automatic
skip patterns were used to move participants past ques-
tions that were not applicable. Areas covered by the
survey included: medication for tics; behavioural inter-
ventions for tics; and desired outcomes of treatment. On
average, the survey took approximately 30 minutes to
complete.
For the child’s clinical characteristics, parents were
asked to report the child’s age of tic onset, diagnosis of
tic disorders and diagnosis of coexisting conditions.
Open-ended questions probed responses to access to
treatment and diagnosis of TS. Parents and carers rated
the impact of tics on their child’s self-esteem, social rela-
tionships and academic performance using the overall
impairment scale of the Yale Global Tic Severity Scale
(YGTSS) [22], adapted for online self-report.
Parents’ views on commonly used drugs (clonidine, ris-
peridone, aripiprazole, sulpiride, haloperidol, olanzapine,
quetiapine, pimozide, clonazepam and lorazepam) were
sought, plus an option to comment on non-specified drug
treatment. The 10 drugs were selected based on a recent
survey of choice of medication for tics among members of
the European Society for the Study of TS (ESSTS) [8] and
our expert panel reports of current prescribing practices
in the UK.
Participants were presented with a brief description
of the comprehensive behavioural intervention for tics
(CBIT) derived from the therapist guide for behav-
ioural intervention for children and adults [23]. The
description included components of habit reversal and
function-based intervention (i.e., contingency management).If this treatment was not reported, parents were asked if
they would like their child to be offered behavioural inter-
vention for tics. Parents had the option to use text boxes
for additional comments throughout the survey.
Finally parents were asked to rank, from most import-
ant to least important, seven potential positive outcomes
of treatment for tics. In addition, parents were presented
with two open-ended questions: i) “What would you
most hope a treatment for tics would do for your child?”;
and ii) “Are there any other benefits from treatment that
you would like to see?”.
Interviews with young people
An interview schedule was developed in consultation
with the expert panel and used to guide exploration of
young people’s thoughts and experiences concerning ser-
vices and treatments for tics. For young people who had
not received medication and/or behavioural intervention
for tics, the interview schedule included a short verbal
description of each of these treatments.
Interviews were conducted by telephone or, where
practical, face-to-face. Where the young person had
been unable to recall specific information (e.g., name
of a drug), permission was sought to check with the
parent. Interviews, which lasted, on average, 40 minutes
(range 20 to 73) were digitally recorded and tran-
scribed verbatim following completion. Any personal
identifiers were removed from the transcript.
Data analysis
To integrate the qualitative data of the interviews of
young people with TS with the quantitative and qualita-
tive data of the survey of parents a process of triangula-
tion was used, where the data from interviews and the
data from the survey were analysed separately and the
results drawn together where appropriate [24]. This per-
mitted the examination of agreement, complementarity
or disagreement [24] between the findings from the in-
terviews with young people with TS and the survey of
parents.
The study reported here adhered to the standards of
reporting qualitative research (RATS) [25].
Parents’ survey
The survey data were analysed using SPSS v19 [26]. The
numerical data reported were calculated based on the
number of responses to each item and exclude missing
values. Text data from open-ended questions were ana-
lysed using an inductive content analysis approach. Con-
tent analysis allows organisation of a large amount of
text into fewer and meaningful categories [27]. The
categories were developed by reading the participants’
responses to gain an overall sense of the data; developing
codes to capture key concepts; labeling the codes,
Table 1 Characteristics of survey participants (n = 295)
Characteristic
Age in years, Mean (SD), Range 44.0 (6.3), 27-68




Marital status, n (%)
Married/cohabitating 201 (78.2)
Other 56 (21.8)
Highest level of education, n (%)
Did not complete secondary
school/compulsory education
7 (2.7)
Secondary school 58 (22.7)
Further education (e.g., A-Level) 85 (33.2)
Undergraduate or postgraduate 106 (41.4)
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finally defining the categories [27].
Interview analysis
The interview data were analysed using thematic analysis
[28]. The purpose of the analysis was to explore young
people’s needs and perceptions of treatments for tics.
The themes were developed inductively because little is
known about young people’s perceptions of different
treatment strategies for tics. This inductive approach is
used when past research in a topic is scarce and it is not
possible to develop theory or research driven themes
[28]. To become familiar with the data, the interview
transcripts were read repeatedly and ideas about key as-
pects of the data were noted down to develop initial
codes. These codes helped to organise the data into
broader categories and they were revised and combined
to identify possible themes. The themes and subthemes
were discussed and refined following discussion with a
qualitative expert leading the study (CG). In order to es-
tablish reliability a code book was developed which, for
each theme, listed: i) the descriptive label; ii) the definition
of the theme; iii) pointers to look for when identifying the
theme; iv) exclusions to the theme; and v) a sample extract
[28]. To establish the reliability of the coding one or two
extracts from each of the themes and subthemes (total
n = 26) were presented, unlabelled, together with the
code book to a qualitative researcher (RW) who was not
involved in the study. The researcher, who was blind to
the original coding, used the codebook to code themes
and subthemes. Her ratings were compared to the ori-
ginal coding by the study research fellow (JC) and agree-
ment was excellent (92.3%, 24/26). Analysis of the
interview data revealed eight superordinate themes re-
lating to the young people’s experiences of treatment
and care for TS of which seven had subthemes.
Results
Characteristics of parent sample
A total of 358 respondents consented to participate in
the survey of whom 297 answered at least one question
on treatment utilisation. Two entries were identified as
repeat respondents and were removed from the data
analysis, resulting in 295 participants with usable data.
Of the 295 participants, 276 (93.6%) reported that their
child had received a diagnosis of TS, eight (2.7%) re-
ported a diagnosis of one or more tic disorders (3 vocal
tic disorder, 2 transient tic disorder and only 3 reported
one or more tic disorders) and 11 (3.7%) did not report
a diagnosis of TS or tic disorder or had missing values
on these items. All 11 reported age of onset for tics and
were included in the analysis.
As shown in Table 1, the majority of participants were
biological mothers (92.2%, n = 237) and the mean age ofthe sample was 44 years (SD = 6.3). Parents and carers
described young people’s demographic and clinical char-
acteristics. Young people (234 males, 61 females) ranged
in age from 5 to 17 (M = 12.4, SD = 3.0). The mean age
of tic onset was 5.9 years (SD = 2.8, range 1 to 17) and
the mean age at diagnosis of TS was 9.1 (SD = 2.7, range
3–17). On average, parents reported that in the last
seven days their child’s tic-related impairment was mild
(M = 2.3, SD = 1.5, range 0 to 5). Sixty-six percent had
one or more co-occurring conditions. Frequently reported
co-occurring conditions were obsessive compulsive dis-
order (35.9%, n =106), ADHD (30.2%, n = 89), anxiety
(24.7%, n = 73), autism spectrum disorder (20.3%, n = 60),
depression (10.8%, n = 32) and learning disability (9.8%,
n = 29).
Characteristics of young people’s sample
Eighty four potential participants provided contact de-
tails and 61 replied to the initial contact. Of these, four
were excluded; three because service or treatment for
tics was provided outside the UK and one was too young
for inclusion. Of the remaining 57, five declined partici-
pation when contacted to arrange an interview, six could
not identify a convenient time and four failed to keep
their interview appointment. These 15 cases did not dif-
fer significantly in age and gender from the 42 young
people who were interviewed (40 by telephone, 2 face-
to-face). Of the 42 young people with TS who took part in
the interviews, the majority were males (76.2%, n = 32)
and the median age of the sample was 13 years (range 10
to 17) (Table 2). Twenty-three (54.8%) participants had
taken medication for tics (median number of drugs taken
= 1, range 1 to5). Eight (19.0%) young people had received
some form of behavioural treatment for tics (median
Table 2 Characteristics of interview participants (n = 42)
Characteristic





White British 36 (85.7)
Mixed/Multiple ethnic groups 6 (14.3)
Co-occurring conditions as reported by child’s
parent (may be more than one condition), n (%)
20 (47.6)
Attention-deficit/hyperactivity disorder 9 (21.4)
Obsessive compulsive disorder 7 (16.7)
Autism spectrum disorder 6 (14.3)
Anxiety 4 (9.5)
Other 5 (11.9)
Treatment for tics, n (%)
Medication 23 (54.8)
Behavioural intervention 8 (19.0)
No medication or behavioural intervention 18 (42.9)
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seven had also received medication [see Additional file 1
for the characteristics of each interviewee].
Analysis of qualitative data from interviews with young
people is presented below and linked, where appropriate,
to survey responses and common themes which
emerged from analysis of text box data from the parent
survey.
Need for access to informed and expert care
Young people spoke about the importance of receiving
care from health professionals with a good understand-
ing of TS, and about the challenges accessing specialist
care. This was quite a strong theme expressed by 22
young people. Views clustered in three subthemes.Perceived lack of understanding of TS among health
professionals
This subtheme captures how some young people felt
that health professionals have insufficient knowledge to
recognise TS and limited training in providing adequate
treatment. Some young people described attending differ-
ent health services to receive treatment for tics because
many of the services they had visited had a poor under-
standing of their condition.
“…most of the places we have been to about my
Tourettes like it seems like no one actually knows
about it, like we know more than them… when we go
there they usually ask us about it more than we ask
them” [P 40]
Difficulties accessing or maintaining specialist care
This subtheme describes how some young people felt
that there were difficulties in receiving specialist treatment
such as delays, cancellations or insufficient funding. This
subtheme also captured young people’s perceptions that
they had received little or no information about TS and
tics from their health professionals.
“…After I got diagnosed two years after that, that’s
when I started to get information about it. …I would
have liked it to have been just more of a frequent thing
when I actually needed the help more. Some sort of like
guidance on things I could do, instead of just finding
out that I had to deal with it all on my own.” [P 32]
Importance of receiving informed specialist care
This subtheme reflects how young people particularly
valued receiving care from health professionals who had
a good understanding of TS and tics. In relation to this,
young people spoke about feeling understood and more
confident, and they considered that knowledgeable
health professionals could provide useful information to
better understand their condition.
These views were strongly echoed in the survey data
with parents. Text boxes probed parents’ perceptions of
access to care and the diagnosis of TS and the resulting
content analysis showed that almost 32% (94/295) of
parents spontaneously reported that it was difficult to
get a referral to specialist treatment and to access appro-
priate care. Of these parents, 30 commented on the
limited understanding of TS and tics among general
practitioners (e.g., “We were told by our GP he would
grow out of this habit and we were given antihista-
mines”) [see Additional file 2]. Parents’ comments also
revealed that 16.3% (48/295) felt that receiving a diagnosis
of TS was a long and difficult process. Moreover, 14.9%
(44/295) of parents described receiving little information
or support when the child received a diagnosis of TS.
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This theme captured young people’s negative percep-
tions of medication for tics based on their experience of
taking medication or on their understanding of what this
treatment involves. This was a major theme endorsed by
29 young people with three subthemes emerging.
Perceived adverse effects of medication
This subtheme captures how young people who took
medication for tics felt that it caused adverse effects.
These effects were associated with different types of
medication and typically included drowsiness, tiredness,
self-reported depression, nightmares, weight gain and a
sense of not being oneself. For some young people
adverse effects were the main reason for stopping taking
medication or for changing to a different drug, even if
they perceived an improvement in tics.
Perceived limited or lack benefit of medication for tics
This subtheme reflects how some young people who
took medication felt that it left the tics unchanged, had a
positive effect on tics for a limited period of time or that
it worsened their tics.
“I was on a medication called risperidone for a while,
which was helpful to start off with, it certainly had a
noticeable effect but once I had got the level, my
risperidone level sort of steady after about a year or
after about six months it stopped being so effective so
I went off it…” [P 29]
Concerns about taking medication for tics
This subtheme describes how young people who had not
taken medication for tics perceived potential difficulties
about taking drug treatment; including potential adverse
effects, difficulties to remember to take the drug, the
need to take medication for a prolonged period of time
and the unpleasant taste of medication. In general,
young people queried whether taking medication would
harm their health.
Parents’ responses showed they shared young people’s
concerns regarding adverse effects of medication. The sur-
vey showed that 54.7% (152/278) of parents mentioned
that their child had taken medication for tics. As shown in
Table 3, for most of the drugs examined, more than 46%
of parents felt that the drug had moderate or severe ad-
verse effects. Parents’ free text comments also suggested
that parents were concerned about a wide variety of ad-
verse effects including, most frequently, sleepiness, tired-
ness or drowsiness and weight gain [see Additional file 3].
The level of tic-related impairment was significantly
higher among the group of parents whose child had taken
medication for tics (M = 2.6, SD = 1.6) compared with thegroup of parents whose child had not (M = 1.9, SD = 1.2),
t(273) = 4.2, p < .001.
Positive experiences of medication for tics
This theme describes how young people who had taken
medication for tics felt that it helped them to reduce
their tics or to have better control over them. For some
young people, medication for tics allowed them to feel
less self-conscious about their tics and to disguise them
better when in public. The responses of 18 young people
endorsed this theme.
More than a third (n = 7) of young people who endorsed
this theme commented specifically on aripiprazole.
“I find aripiprazole helps quite a lot actually I am not
as bad as I was. I don’t have many tics during the day
or anything anymore.” [P 10]
In the online survey, parents also identified that medi-
cation could be helpful for the child’s tics. However,
parents’ ratings of perceived helpfulness of medication
were generally moderate. An exception to this was aripi-
prazole (see Table 3). In the interviews, of the 10 young
people who had taken aripiprazole, six also described
adverse effects, the most frequent being drowsiness or
sleepiness (two young people reported dizziness, one
shakiness and one drooling) but only one child had
stopped taking it and this was because it had little posi-
tive effects rather than because of side effects.
Behavioural interventions for tics is a ‘natural’
intervention that could be incorporated into daily life
Positive perceptions of behavioural interventions for tics
were captured by this theme, expressed in two subthemes.
Positive experiences of behavioural interventions for tics
This subtheme describes how young people who had re-
ceived behavioural interventions for tics felt that it helped
them to better recognise, control or manage their tics. Of
the eight young people who had received behavioural in-
terventions for tics, six interviews included this subtheme.
Although the treatment process was often described as
long, young people felt that it was generally helpful.
“…it took me a while but now it works more… I don’t
have to think oh I must bite my lip I just do it
without thinking, but at the time I was just like oh
this isn’t going to work but it got better.” [P 5]
Perceived potential helpfulness of behavioural interventions
for tics
This subtheme reflects how young people who had not
received behavioural interventions for tics generally held
positive views about this treatment. Of the 34 young













Treatment n (%) Mean (SD) n (%) Mean (SD) n (%)
Medication
Risperidone 77 (27.7) 0.1 (1.3) 30 (39.5) 1.9 (1.1) 48 (63.2)
Clonidine 73 (26.3) 0.1 (1.1) 30 (41.1) 1.5 (1.1) 34 (46.6)
Aripiprazole 55 (19.9) 1.0 (1.0 ) 38 (69.1) 0.9 (1.1) 14 (25.5)
Haloperidol 24 (8.7) −0.1 (1.2) 6 (25.0) 1.9 (1.3) 17 (70.8)
Sulpiride 13 (4.7) −0.2 (1.0) 2 (15.4) 1.3 (1.4) 6 (46.2)
Pimozide 7 (2.5) 0.3 (1.3) 3 (42.9) 1.7 (1.4) 4 (57.1)
Clonazepam 7 (2.5) −0.1 (1.5) 3 (42.9) 2.0 (1.4) 5 (71.4)
Lorazepam 5 (1.8) 0.2 (1.3) 3 (60.0) 1.6 (1.5) 3 (60.0)
Behavioural interventions for tics 74 (25.9) 0.4 (1.0) 34 (48.6) 0.4 (0.8) 8 (11.4)
Helpfulness scale: −2 = unhelpful – tics got a lot worse; −1 = unhelpful – tics got a bit worse; 0 = tics stayed the same; 1 = somewhat helpful; 2 = very helpful.
Adverse effects scale: 0 = none; 1 =mild; 2 =moderate; 3 = severe.
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for tics, 15 were represented in this subtheme. Young
people felt that this treatment involved learning and
practising behaviours that were similar to some of the
behaviours they have used to control their tics, and they
were described as “natural”.
Limitations of behavioural interventions for the treatment
for tics
This theme captures young people’s negative perceptions
of behavioural interventions for tics based on their
direct experience of this intervention or on their under-
standing of what this treatment involves. This theme
consists of two subthemes.
Negative experiences of behavioural interventions for tics
This subtheme describes how young people who had
received behavioural interventions for tics felt that it was
unhelpful and difficult to engage with. Of the eight
young people who received behavioural interventions for
tics, the responses of six endorsed this theme. Some
young people felt that it was difficult to execute compet-
ing responses for motor or vocal tics, and one young
person felt that behavioural interventions was changing
“this to that” and remembered developing a tic from a
competing response.
Perceived potential difficulties of behavioural interventions
for tics
This subtheme reflects how young people who had not
received behavioural interventions for tics felt that this
treatment would take long, considerable effort from
their part or much support from others. Of the 34 young
people who had not received behavioural interventionsfor tics, 14 perceived at least some limitations. Some
young people felt that it would be difficult to remember
to do the treatment exercises, that they could interfere
with daily activities or be ineffective for “strong” tics.
In the online survey, 25.9% (74/286) of parents re-
ported their child had received a behavioural interven-
tion but in around half of these cases (36/69) the child
received fewer than five sessions. Compared with par-
ents whose child received fewer than five sessions and
those who reported between five and 10, parents with
more than 10 sessions had the highest scores on per-
ceived helpfulness of behavioural interventions, yet these
differences did not reach significance at p < .05. A higher
proportion of parents whose child had received behav-
ioural interventions for tics reported that their child had
taken medication, χ2(1, n = 278) = 8.9, p < .01.
Eight percent (6/74) of parents commented on the
helpfulness of the treatment and a similar number of
parents identified limitations [see Additional file 4]. Par-
ents (9.5%, 7/74) also commented on how the young
person’s age and tic severity influenced treatment en-
gagement and outcome . Of note, 6.8% (5/74) of parents
described difficulties receiving behavioural interventions
for tics from knowledgeable treatment providers (e.g.,
“More training needed for professionals… and I speak as
both parent and professional!”).
In the interviews with young people, those who had
not received behavioural interventions for tics had both
negative and positive views on this treatment. In con-
trast, in the online survey most parents whose child had
not received behavioural intervention for tics seemed to
have positive perceptions of this treatment. Among par-
ents whose child had not received behavioural interven-
tions, the majority (76.3%, 148/194) wanted their child
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availability of this treatment were limited (22.3%, 33/148)
(e.g., “My daughter has asked time and again for this kind
of help but it isn’t available in X”) [see Additional file 5].
Moreover, 10.8% (16/148) of parents expressed an interest
in behavioural interventions, particularly as an alternative
to medication.
Among parents who did not desire behavioural inter-
ventions for their children, 19.6% (9/46) felt that their
child did not need this treatment because the tics were
currently minimal or manageable [see Additional file 5].
Another 19.6% (9/46) felt that behavioural interventions
would not suit their child and 8.7% (4/46) commented
that these interventions were unavailable when the child
needed treatment.
Desire for a treatment to stop or reduce tics and the urge
to tic
Two thirds of young people (n = 28) spoke about what
they hoped a treatment could offer them. Although com-
monly young people wanted a treatment to reduce tics, re-
ducing the urge to tic emerged as a second important
subtheme.
Wanting to stop or reduce tics
This subtheme describes how young people would like
their tics to be reduced, stopped, taken away or eliminated.
Wanting to reduce urges to tic
Reflects how for some young people the urge to tic was
perceived as uncomfortable or painful, and reducing it
was seen as an important outcome of treatment.
“I would like something that would kind of stop the
urge to do it all the time…” [P 34]
Interestingly parents did not identify controlling the
urge to tic as one of their desired outcomes of
treatment.
Need to manage emotional responses associated with tics
During the interviews young people also spoke about
wanting a treatment that could help them to reduce or
manage negative emotions associated with tics. This
theme was endorsed by 19 young people and it consists
of two subthemes.
Negative emotions as contributing to tics
This subtheme describes how young people spoke of
feeling worried, anxious, or stressed in relation to their
tics. Some young people remembered experiencing these
emotions in different situations, particularly social situa-
tions, and considered that these emotions worsened
their tics.“…it makes me worried and then because I am
worried I do it [tic] more and then because I am
doing it more and people are looking I do it even
more than that.” [P 19]
Interest and attempts to reduce negative emotions
associated with tics
This subtheme captures young people’s efforts to reduce
self-reported anxiety-related emotions that were associ-
ated with tics. For some young people, these emotions
were described as more troublesome than tics and they
spoke about trying to find ways to reduce them. Some
young people described wanting a treatment that could
help them to feel relaxed and calmed.
The importance of gaining a sense of control over TS
Half of the young people (n = 21) spoke about experien-
cing little or no control over tics and identified a sense
of control as an important outcome of treatment.
Perceived lack of control over TS and tics
This subtheme reflects how some young people felt that
their tics could “take over”; as if these had their own will
or personality.
Need to gain control over TS and tics
This subtheme describes how young people tried or
would like to stop their tics at their instigation. They felt
that this would allow them to engage in other activities,
such as school activities, “without having to think my
tics are going to get in the way” [P 23].
In the survey, parents ranked “reduction in severity
and frequency of your child’s tics” as the most important
desired outcome of treatment [see Additional file 6].
This was confirmed in approaching half the text com-
ments [see Additional file 7]. Again, in line with the
young people’s priorities, almost a quarter (64/295) of
parents hoped that treatment for tics would help the
child to reduce negative emotions associated with tics,
which were often described as worries, anxiety and frus-
tration (e.g., “…stop him feeling anxious… Let his body
have some peace and be able to relax without ticking”),
and 19.3% (57/295) felt that a treatment should help the
child to control the tics [see Additional file 7].
Discussion
This study explored perceptions of treatments for tics by
conducting in-depth qualitative interviews with young
people with TS and a mixed-methods survey of parents’
views on their child’s treatment for tics. There were
many commonalities between the views of the separate
groups of parents and young people. Young people and
parents expressed strong concerns that health profes-
sionals have limited knowledge of TS and this was often
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evidence-based treatment. Young people and parents
described the benefits of medication for tics, aripipra-
zole being favourably perceived, yet both groups also
described concerns about adverse effects of medication
and these were a common explanation for stopping
medication among young people. Access to behavioural
interventions for tics seemed to be limited and young
people and parents had mixed views on these interven-
tions, yet they were generally welcomed as having few ad-
verse effects. Reducing or stopping tics was a desired
outcome of treatment for young people and parents, but
so was gaining a sense of control over tics and reducing or
managing negative emotions which families attributed to
being associated with tics. Young people particularly
highlighted the need to manage the discomfort and dis-
tress associated with the urge to tic but this was not
recognised by parents.
The findings of this study suggest that young people
with TS and parents have had difficulties getting a diag-
nosis of TS, getting referred to specialist treatment and
receiving appropriate treatment for tics. Consistent with
past research that has found delays in the diagnosis of
TS [17], the survey of parents identified an average delay
of three years between age of tic onset and age of diag-
nosis of TS. Parents’ comments further suggested that
getting a referral to specialist treatment was a long and
difficult process. In many cases health professionals, par-
ticularly at primary care level, were perceived as having
a poor understanding of tics and there were many exam-
ples of insensitive or ill-informed communications. In
relation to this, in the interviews young people described
visiting many services in attempts to receive treatment
for tics and perceived that their condition was not well
understood among health professionals. A previous
study showed that approximately a quarter of health
professionals lacked general knowledge of TS and only
52% were aware of its diagnostic criteria [29]. Moreover,
a recent case note study of children with TS presenting
at a UK non-specialist service found that at first consult-
ation 76.5% of GPs thought that the symptoms did not
indicate TS or tic disorders, and only 12.5% of GPs
referred the child to a specialist service [30]. Current
clinical guidelines recommend that health professionals
work closely with patients, parents and other key carers
in providing information about tics and their treatment
[13,15,16]. However, in addition to difficulties with diag-
nosis and access difficulties, the findings of the present
study indicate that some young people who had received
medication or behavioural interventions for tics per-
ceived that health professionals had insufficient training
in providing treatment.
Consistent with previous survey studies, medication
was a frequently reported treatment for tics amongyoung people [9,10] and risperidone, clonidine and aripi-
prazole were the three most commonly reported drugs
[11]. Some young people and parents had positive per-
ceptions of medication. For parents, aripiprazole was
generally perceived as helpful for the child’s tics and
with few adverse effects. Children also perceived that
aripiprazole was effective and it also appeared to be well
tolerated although, since the doses of each target drug
were not known, it is not possible to determine the im-
pact of dosage. It may be that aripiprazole is better toler-
ated than other antipsychotic medication. There is some
evidence suggesting that aripiprazole might be an effect-
ive treatment in reducing tics [31] and this has been
confirmed in a recent randomised trial [32]. Young
people had varied experiences of medication for tics and
benefits of medication were generally described in terms
of a reduction of tics, better control of tics and feeling
less self-conscious about tics. Adverse effects, however,
were commonly described by young people and parents.
For young people adverse effects varied, were experi-
enced with different drugs and were a common reason
for stopping medication which highlights the importance
of informed choice with regard to medication.
The study suggests that access to behavioural interven-
tions is limited and that young people and their parents
have mixed views about this treatment; however, a com-
mon theme for young people and parents was the lack
of adverse effects. A previous US survey of parents of
young people with TS suggested only 23.6% received be-
havioural treatment [10]: very close to the 25.9% re-
ported by parents in the present study. In addition to
limited availability the results of the parent survey and
the interviews with young people suggest that many may
not receive sufficient “dose” of behavioural intervention,
with parents reporting that most of those who receive
this treatment get fewer than five sessions and young
people reported a median of four sessions. Eight or more
sessions have been recommended for CBIT [23] and 12
for exposure and response prevention (ER) which is an
extension of habit reversal [33]. It is unclear why rela-
tively few participants in the present study had received
behavioural interventions for tics but it has been sug-
gested [34] that this could be due to health professionals’
lack of knowledge regarding implementation [29] and
difficulties finding treatment providers [10]. Parents’
comments indicated that 22% of those who wanted be-
havioural interventions for their child’s tics felt that
health professionals lacked awareness or training in this
approach.
Some parents and young people felt that behavioural
interventions were helpful for managing tics, whereas
others reported difficulties engaging with this interven-
tion and a few parents and young people described nega-
tive reactions such as attributing a new tic to treatment
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ioural interventions seemed to be linked to the duration,
motivation and effort needed to practise this treatment,
rather than to adverse effects. Using data from two large
CBIT trials of children and adults, a recent study exam-
ined frequently reported concerns of CBIT including the
claim that this intervention requires considerable effort
for patients and that it contributes to tic substitution
[14]. The study suggests that CBIT may not require
considerable effort for patients since attrition in the tri-
als was low (9.5% to 13.9%) and comparable to placebo-
controlled medication trials [14]. In addition, the study
suggests that CBIT does not result in tic substitution
since in both trials there was an improvement in the
YGTSS scores [14]. Since the present study examined
perceptions of treatment for tics, its findings suggest
that these concerns exist in some young people with TS
and their parents, and that health professionals may
need to address these concerns when providing behav-
ioural interventions. There is evidence that behavioural
interventions for tics can be effective in reducing tics
[35] and current clinical guidelines suggest such inter-
ventions as a first line treatment [12-14]. To increase the
accessibility of behavioural interventions for tics other
forms of delivery could be further investigated, such as
videoconference for which there is some preliminary
evidence of its effectiveness [36].
A novel feature of these results was the importance
that both parents and young people placed on managing
the negative emotions associated with TS which were
generally described as worries, anxiety and stress. Past
research suggests that anxiety, stress and tension are
linked to tic exacerbation [37]. The present study seems
consistent with this, but further suggests that young
people and parents hope that a treatment for tics helps
them to manage anxiety-related symptoms. Treatment
outcome measures could incorporate the evaluation of
anxiety and stress related to tics. Gaining a sense of con-
trol over tics was also mentioned by young people and
parents. In relation to this, a previous qualitative study
with young people with TS identified that young people
felt that they needed to control their tics [4]. For young
people, help to deal with the urge to tic was important
but parents did not recognise this outcome as important.
In this regard, ER is one behavioural intervention for tics
that has shown to reduce the urge to tic by teaching the
child to resist the urge as long as possible [38]. Research
is needed to explore the scope of tailored behavioural
interventions to deliver treatment outcomes that are
important to young people.
Strengths and limitations
The survey had a large sample size (n = 295) which closely
approximated the minimum of 300 recommended byParker et al. [21] to ensure valid results. By using an
anonymous online survey, parents had the opportunity
to describe both positive and negative perceptions of
treatment for tics, whereas the individual interviews
with young people might have reduced the potential
influence of other young people’s opinions if data were
collected in groups. Although only 20% of the children
who were the subject of the survey and 23% of young
people who were interviewed were female this is a
close reflection of the 20%-25% female prevalence ob-
served in representative samples of children with TS
[39]. Participants were recruited through Tourettes
Action (TA); membership or communication with TA
may reflect a proactive population with common views
on specific treatments for tics and the findings, based
on a UK population, may not generalise to all young
people with TS. Although we would have liked to re-
cruit more participants who had direct experience with
behavioural interventions for tics, the relatively small
proportion of parents and young people who received
this treatment might reflect its limited availability in a
UK population. Recall bias may have influenced par-
ents’ and young people’s perceptions of treatments for
tics, particularly if the young person received treat-
ment several years before data collection. Some young
people chose to be interviewed with their parent
present which might have influenced responses. However,
young people seemed to talk openly and to consult the
parent only when they were unable to remember details of
treatment, such as a drug name or the time when they re-
ceived an intervention. Interviews were conducted and
analysed by one researcher (JC) who had previous experi-
ence of working with children and young people but who
was not an expert on TS. As someone who not involved
in the setting of the original research questions or in clin-
ical care, arguably interactions with participants were not
strongly driven by the interviewer’s preconceptions about
treatment.
Conclusions
Many young people and their parents in the present
study perceived that TS and tic treatments are generally
not well understood among health professionals. Be-
cause they described difficulties accessing specialist
treatment and appropriate care, it is in the interest of
young people and their parents that professional training
expands knowledge and awareness of TS and tic treat-
ments among health professionals, particularly at primary
care level. Since medication was a common treatment for
tics and many parents and young people perceived adverse
effects of medication, young people and their families may
value receiving clear information regarding the rationale
for using medication and its potential adverse effects. Be-
havioural interventions for tics were generally perceived
Cuenca et al. BMC Psychiatry  (2015) 15:46 Page 11 of 12as having little or no adverse effects, but access to and
knowledge of this treatment seemed limited and further
research could investigate if its accessibility could be in-
creased through the use of technology. Stopping or redu-
cing tics was clearly a desired outcome of treatment, but
so was managing anxiety related to tics and gaining a
sense of control over tics, which could be incorporated in
the evaluation of treatment outcomes.Additional files
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